Patent · US Active

Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use

US11603411B2 · kind B2 · utility

5Cited by

95References

5Claims

0Family size

Assignee

Hoffmann-La Roche Inc. · US

Inventors

Harald Duerr · Starnberg, DE
Sebastian Fenn · Clapham, GB
Ulrich Goepfert · Penzberg, DE
Sabine Imhof-Jung · Planegg, DE
Christian Klein · Iffeldorf, DE
Laurent Lariviere · Ostendorf, DE
Michael Molhoj · Munich, DE
Joerg Thomas Regula · Munich, DE
Petra Rueger · Penzberg, DE
Wolfgang Schaefer · Sankt Augustin, DE

Key dates

Filing date	Mar 30, 2018
Grant date	Mar 14, 2023
Priority date	—
Expiry date	Mar 30, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/94
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

Herein are provided bispecific anti-human CD20/human transferrin receptor antibodies and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.